real-world-data-map

Real-World Data and Scientific Solutions

Curating and transforming real-world data into impactful, actionable evidence

Patient-level real-world data (RWD) have the potential to save drug developers hundreds of millions of dollars by accelerating drug trials, expanding approvals, optimizing pricing and reimbursement models, and more.

According to the U.S. Food and Drug Administration (FDA), the term “real-world data” refers to information related to patient health status and the delivery of health care routinely collected outside of traditional clinical trials. These data sources are abundant, including electronic health records (EHR), medical claims and billing, patient registries, patient-reported outcomes, wearables, patient-mediated platforms and patient-generated data.

Technology has enabled immense growth in RWD sources and increased our ability to access, link and analyze those data. The real power of RWD lies in its transformation into actionable real-world evidence (RWE) to inform decision-making, ensure safety, enhance patient outcomes, support market access and drive innovation. Our team is uniquely positioned to help clients unlock the value of these data.

Harness the power of RWD to unlock vital insights that help you demonstrate the value of your product to your key stakeholders. Take your research further with the right data, to generate the right evidence, at the right time and for the right audience.

Real-world evidence for real-life insights

In today’s health care environment, RWD and RWE play a valuable role across the drug development life cycle continuum, answering questions and filling gaps at every stage. Advance your drug development plan and inform crucial decision-making through the use of real-world evidence, including:

Informing strategies and trial design

  • Understanding natural history of the disease, epidemiology, treatment landscape and burden of illness
  • Identifying patient populations and patient profiles
  • Providing comparative data for single-arm studies

Monitoring and assessing safety

  • Informing benefit/risk profiles of products
  • Detecting adverse events
  • Evaluating post-market safety and effectiveness

Ensuring patient-centricity

  • Optimizing recruitment, retention and trial design
  • Assessing impact of treatments on patient outcomes
  • Improving patient diversity and sub-group identification
  • Incorporating patient preference and insights research

Strengthening regulatory and market access value positioning

  • Demonstrating economic value and comparative effectiveness insights
  • Predicting provider patterns to optimize market access and real-world uptake
  • Fulfilling post-marketing commitments

Explore how real-world evidence can enhance, advance and improve your research and development goals. Let’s partner to produce better outcomes.

Navigating the challenges of real-world data

The true potential and power of real-world data (RWD) are realized in their evaluation, curation, enrichment, analysis and interpretation. The rapid increase in RWD sources and use comes with its own considerations, including:

  • Privacy: Patients have a right to know how their personal data will be used, and the privacy regulations vary by country or geography. Understanding the data requirements across geographies and how to efficiently navigate differing regulations can equate to valuable time and resource savings.
  • Data quality and standardization: Not all data are equal. Data received from various, disparate sources are often incomplete and require assessment and standardization to ensure the highest quality, compliant data are used effectively.
  • Identification of the right data: Choosing the most effective RWD for your specific needs can be daunting. Deep knowledge and insight into the evolving data landscape is critical to understand existing data options, identify which data are best for your research questions and assess if new RWD generation is needed through additional studies.
  • Advanced analytic expertise: The value of data is unlocked through analysis. Extracting deeper, more meaningful insights that optimize the potential of big data requires enhanced methods such as machine learning and advanced artificial intelligence (AI).
  • Understanding of RWD value: The uses for RWD are continually expanding to support every stage of product development, from early development to post-launch. Our specialized expertise enables you to understand the full potential of RWD and discover how to use data differently to innovate your data solutions.
real-world-data-globe

With an extensive network of data resources, we provide access to exceptional quality data

0 +

Proprietary disease registries

0 M

Health care providers in our proprietary global network

0 M

Patients in our proprietary EHR retina database

0 +

Diverse global data sources with which we have deep understanding and application experience

0 +

Partnerships with industry-renowned RWD providers

Optimizing data solutions with an integrated, strategic approach

Make the most out of the advances in real-world data and evidence by partnering with us to apply a strategic approach to RWD access, generation, analysis and integration into your overall development plan.

A comprehensive understanding of your research questions is our first priority in supporting your product development. Every study is an opportunity to define unique strategic insights and develop innovative solutions to optimize study efficiencies, reduce research burden and improve evidence. Whether your observational study needs can be met with existing secondary data, or you require the design and execution of hybrid study approaches or prospective data collection, we ensure a tailored solution that drives your product forward.

Team of professionals reviewing external control arms data on a tablet.
vantage-data-dashboard

Real-world data visualization

Get fast, on-demand access to real-world data — from flexible cross-sectional analysis to powerful visualizations and longitudinal tracking — with our real-world data visualization platform.

Easily interrogate U.K. Primary Care Activity Data (PCAD), Hospital Episode Statistics (HES), Quality and Outcomes Framework (QOF) and prescribing data to identify trends and clinical insights to support improved patient outcomes.

Create bespoke animated models to simulate health care pathways that illustrate the impact of introducing a new intervention or service change. This powerful, interactive tool supports internal and external interactions, providing improved access and communication of RWD, including our proprietary datasets and/or your own data or external data sources.

Leveraging global experience

Our expert scientific team prioritizes keeping up with the constantly changing RWD landscape and the availability of new data sources. With staff from a variety of disciplines, including clinicians, epidemiologists, data analysts, biostatisticians and data technology experts, we enable our clients to effectively use RWD and RWE to advance their product development for successful market access and uptake.

0 +

Years of experience designing and operationalizing global, real-world studies

0 +

RWE professionals and data scientists

0 +

Retrospective database studies (in the past five years)

0

Prospective, observational studies (in the past five years)

AI

Successful deployment of advanced technologies, such as artificial intelligence, machine learning and natural language processing

Reliable

Methodological expertise and rigor to enhance the reliability of results

Real-world data have transformed drug development, offering deeper and richer insights than clinical trial data alone can provide. By leveraging RWD, stakeholders can make evidence-based, informed decisions at every stage of development, leading to improved efficiencies, stronger evidence and better access to life changing interventions.

Harness the power of real-world data to transform your drug development program